Red light therapy shows promise for controlling myopia in children

NCT ID NCT05606237

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether a low-level red-light device can slow the progression of myopia (nearsightedness) in children aged 8 to 13. Participants use the device for 3 minutes twice a day. The goal is to see if it reduces eye growth and prevents worsening vision, building on promising results from a Chinese study.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Low-level red-light therapy device
What this could lead to
If successful, this could offer a quick, non-invasive way to control myopia in children, reducing the need for glasses or contacts.
What could go wrong
This is a small, early-stage trial with no control group, so results may not be definitive. The therapy requires twice-daily sessions, which may be hard to maintain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of California, San Francisco

    RECRUITING

    San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.